Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade

Ganapathy Srirama David. H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USAView further author information

Tiffany R. Emmonsa David. H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA;b Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA;c Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA;d Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA, USAView further author information

Lauren E. Millinga David. H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA;b Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USAView further author information

Darrell J. Irvinea David. H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA;b Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA;e Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA;f The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA;g Howard Hughes Medical Institute, Chevy Chase, MD, USAView further author information

Michael B. Yaffea David. H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA;b Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA;c Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA;d Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA;h Divisions of Acute Care Surgery, Trauma, and Surgical Critical Care and Surgical Oncology, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USACorrespondence[email protected]

https://orcid.org/0000-0002-9547-3251 View further author information

Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date